SCHEMBL9721793

SCHEMBL9721793

CNC(=S)Nc1ccncc1N

nearest known ligand 0.60

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ MAPT P10636 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HDAC3 O15379 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9425432 0.86 ALDH1A1 (0.45) ALDH1A1MAPTKDM4EGAALMNA
Hydrochloric Acid SCHEMBL9426498 0.85 ALDH1A1 (0.44) ALDH1A1MAPTKDM4EGAALMNA
SCHEMBL18858122 0.79 KDM4E (0.39) ALDH1A1MAPTKDM4EGLAGAA
SCHEMBL2046959 0.75 — —
SCHEMBL30074192 0.75 — —
SCHEMBL9426430 0.75 KDM4E (0.50) ALDH1A1MAPTKDM4EGLAGAA
SCHEMBL13568860 0.74 HDAC3 (0.47) ALDH1A1MAPTKDM4EGAAHDAC3
Hydrochloric Acid SCHEMBL27703391 0.74 AOC1 (0.53) ALDH1A1MAPTKDM4EGLAGAA
SCHEMBL28824138 0.73 KDM4E (0.53) ALDH1A1MAPTKDM4EGLAGAA
SCHEMBL15432244 0.72 KDM4E (0.56) ALDH1A1MAPTKDM4EGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111205310-B Heterocyclic fused pyrimidine derivative, pharmaceutical composition and application thereof 上海迪诺医药科技有限公司 2023-12-19 — — CN disclosed
CN-111205310-A Heterocyclic fused pyrimidine derivative, and pharmaceutical composition and application thereof 上海迪诺医药科技有限公司 2020-05-29 — — CN disclosed
US-5137896-A Useful in treatment of gastrointestinal and psychic disorder; analgesic, antiemetic and antiulcer agent JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-11 — — US disclosed
US-5057525-A Stimulators of gastrointestinal motility JANSSEN PHARMACEUTICA N.V. (BE) 1991-10-15 — — US disclosed
US-4962115-A Stimulate motility of gastrointestinal system JANSSEN PHARMACEUTICA N.V. (BE) 1990-10-09 — — US disclosed
EP-0076530-B1 NOVEL N-(3-HYDROXY-4-PIPERIDINYL)BENZAMIDE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1985-12-11 — — EP disclosed
EP-0076530-A2 Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1983-04-13 — — EP disclosed
Send feedback